AI-Assisted Drug Re-Purposing for Human Liver Fibrosis.

FCM results also revealed that the TGFBR1, p38, GSK3β, and HDAC inhibitors increased the number of liver parenchymal (EPCAM + ) cells in TGFβ‐treated microHOs ( Figure 2 A–D ); while the BRD4i induced‐increase in epithelial cells did not reach statistical significance.

also in 111,027 other papers